| Class 2 Device Recall TDx/TDxFLx and TDxFLx Gentamicin Reagents | |
Date Initiated by Firm | November 17, 2003 |
Date Posted | July 20, 2004 |
Recall Status1 |
Terminated 3 on November 01, 2004 |
Recall Number | Z-0278-04 |
Recall Event ID |
27780 |
510(K)Number | K840826 K871645 |
Product Classification |
Enzyme Immunoassay, Gentamicin - Product Code LCD
|
Product | Package Insert for TDx/TDxFLx and TDxFLx Gentamicin Reagents, REF 9512, item numbers 34-1074/R3 and 69-5120/R2; Abbott Laboratories, Diagnostics Division, Abbott Park, IL 60064 |
Code Information |
Reagent List 9512-60,lots 06313Q100, 01368Q101, 95380Q100, 93579Q100, 90107Q100; and Reagent List 9512-85, lots 06312Q100, 02010Q100, 96606Q100, 95106Q100, 90108Q100 that contain insert item numbers 34-1074/R3 or 69-5120/R2 |
Recalling Firm/ Manufacturer |
Abbott Laboratories HPD/ADD/GPRD 100/200 Abbott Park Road Abbott Park IL 60064
|
For Additional Information Contact | Abbott Customer Support 877-422-2688 |
Manufacturer Reason for Recall | The package inserts contain incorrect values for the alternate unit (mol/L) Control Ranges |
FDA Determined Cause 2 | Other |
Action | Field Correction recall by undated letter sent on 11/17/03 to all customers receiving the affected lots of reagents. The accounts were informed of the incorrect values for the alternate unit (mol/L) Control Ranges listed in the package inserts of the reagent kits. The letters contained a table listing the incorrect values and the correct values for each of the products, and the users were instructed to use the correct values listed in the table for the assays. The letters also listed the package insert item numbers for the updated inserts being used in current reagent production. |
Quantity in Commerce | 9,010 kits |
Distribution | Nationwide and internationally through Abbott subsidiaries in Mexico, Guatemala, Venezuela, Colombia, Peru, Chile, Uruguay, Argentina, Brazil, Puerto Rico, San Salvador, Canada, Germany, England, Japan, Singapore, Hong Kong, India, Taiwan, Thailand, Malaysia, Pakistan, Korea, Australia, New Zealand, Honduras, Costa Rica, Aruba, Bahamas, Panama, St. Croix, Jamaica and Paraguay. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = LCD
|
|
|
|